Altered alpha adrenergic vasoresponsiveness in a non-cirrhotic portal hypertension model of E. coli injection

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 6, 2007, Pages 870-876

  Rizvi, Moattar Raza ^a   Omanwar, Swati ^a   Fahim, Mohammad ^b   Sarin, Shiv Kumar ^a,c  

^a G B PANT HOSPITAL   (India)

^b UNIVERSITY OF DELHI   (India)

^c UNIVERSITY OF DELHI   (India)

Author keywords

Escherichia coli; Non cirrhotic portal fibrosis; Non cirrhotic portal hypertension; Portal hypertension; Portal pressure; Variceal bleeding; Vascular reactivity

Indexed keywords

ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR; LIPOPOLYSACCHARIDE; NIFEDIPINE; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NONHUMAN; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RABBIT; RANDOMIZATION; SPLEEN WEIGHT; VASCULAR RING; VASODILATATION;

EID: 34250380711     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04440.x     Document Type: Article

References (43)

1. Sarin SK. Non-cirrhotic portal fibrosis. Gut 1989 30 : 406 15.
2. Okuda K, Kono K, Ohnishi K et al. Clinical study of 86 cases of idiopathic portal hypertension and comparison with cirrhosis and splenomegaly. Gastroenterology 1984 86 : 600 10.
3. Reichen J. Liver function and pharmacological considerations in the pathogenesis and treatment of portal hypertension. Hepatology 1990 11 : 1066 78.
4. Trombino C, Tazi KA, Gadano A, Moreau R, Lebrec D. Protein kinase C alteration in aortic vascular smooth muscle cells from rats with cirrhosis. J. Hepatol. 1998 28 : 670 6.
5. Kathayat R, Pandey GK, Malhotra V, Omanwar S, Sharma BK, Sarin SK. Rabbit model of non-cirrhotic portal fibrosis with repeated immunosensitization by rabbit splenic extract. J. Gastroenterol. Hepatol. 2002 17 : 1312 16.
6. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin and Ciocalteu's phenol reagent. J. Biol. Chem. 1951 193 : 265 75.
7. Sogni P, Sabey S, Moreau R, Gadano A, Lebrec D, Dinh-Xuan AT. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats. J. Hepatol. 1996 24 : 487 90.
8. Sarin SK, Sharma G, Banerjee S, Kathayat R, Malhotra V. Hepatic fibrogenesis using chronic arsenic ingestion: studies in a murine model. Indian J. Exp. Biol. 1999 37 : 147 51.
9. James DG, Sherlock S. Sarcoidosis of the liver. Sarcoidosis 1994 11 : 2 6.
10. Williams DM, Smith PM, Taylor KJ, Crossley IR, Duck BW. Monitoring liver disorders in vinyl chloride monomer workers using greyscale ultrasonography. Br. J. Ind. Med. 1976 33 : 152 7.
11. Sarin SK, Mehra NK, Agarwal A, Malhotra V, Anand BS, Taneja V. Familial aggregation in noncirrhotic portal fibrosis: a report of four families. Am. J. Gastroenterol. 1987 82 : 1130 3.
12. Kono K, Ohnishi K, Omata M et al. Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits. Gastroenterology 1988 94 : 787 96.
13. Zhang MJ. E. coli-induced idiopathic portal hypertension in rabbits. An experimental study. Zhonghua Wai Ke Za Zhi 1992 30 : 115 26.
14. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987 327 : 524 6.
15. Guarner C, Soriano G, Tomas A et al. Increase serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993 18 : 1139 43.
16. Hori N, Wiest R, Groszmann RJ. Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats. Hepatology 1998 28 : 1467 73.
17. Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 1992 103 : 235 9.
18. Sieber CC, Groszmann RJ. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am. J. Physiol. 1992 262 : G996 1001.
19. Atucha NM, Ortiz MC, Fortepiani LA, Ruiz FM, Martinez C, Garcia-Estan J. Role of cyclic GMP and potassium channels as mediators of the mesenteric vascular hyporesponsiveness in portal hypertensive rats. Hepatology 1998 27 : 900 5.
20. Atucha NM, Shah V, Garcia-Cardena G, Sessa WE, Groszmann RJ. Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis. Gastroenterology 1996 111 : 1627 32.
21. Cawley T, Geraghty J, Osborne H, Docherty JR. Effects of portal hypertension on responsiveness of rat mesenteric artery and aorta. Br. J. Pharmacol. 1995 114 : 791 6.
22. Heller J, Schepke M, Gehnen N et al. Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis. Gastroenterology 1999 116 : 387 93.
23. Connolly C, Cawley T, McCormick PA, Docherty JR. Portal hypertension increases vasoconstrictor responsiveness of rat aorta. Clin. Sci. (Lond.) 1999 96 : 41 7.
24. Ortiz MC, Fortepiani LA, Martinez C, Atucha NM, Garcia-Estan J. Vascular hyporesponsiveness in aortic rings from cirrhotic rats. role of nitric oxide and endothelium. Clin. Sci. (Lond.) 1996 91 : 733 8.
25. Murray BM, Paller MS. Pressor resistance to vasopressin in sodium depletion, potassium depletion and cirrhosis. Am. J. Physiol. 1986 251 : R525 30.
26. Castro A, Jimenez W, Claria J et al. Impaired responsiveness to angiotensin II in experimental cirrhosis: Role of nitric oxide. Hepatology 1993 18 : 367 72.
27. Weigert AL, Martin PY, Niederberger M et al. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats. Hepatology 1995 22 : 1856 62.
28. Obbergh LV, Leonard V, Chen H, Xu D, Blaise G. The endothelial and non-endothelial mechanism responsible for attenuated vasoconstriction in cirrhotic rats. Exp. Physiol. 1995 80 : 609 17.
29. Bierbrier GS, Adams PC, Feldman RD. Vascular alpha-adrenergic responsiveness is reduced in cirrhosis. Clin. Pharmacol. Ther. 1994 56 : 668 71.
30. Schmandra TC, Folz IC, Kimpel M, Fleming I, Holzer K, Hanisch EW. Cirrhosis serum induces a nitric oxide-associated vascular hyporeactivity of aortic segments from healthy rats in vitro. Eur. J. Gastroenterol. Hepatol. 2001 13 : 957 62.
31. Kilbourn R. The discovery of nitric oxide as a key mediator in septic shock. Sepsis 1998 1 : 85 91.
32. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991 337 : 776 8.
33. Pizcueta MP, Pique JM, Bosch J, Whittle BRJ, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br. J. Pharmacol. 1992 105 : 184 90.
34. Michielsen PP, Boeckxstaens GE, Sys SU, Herman AG, Pelckmans PA. The role of nitric oxide in hyporeactivity to noradrenaline of isolated aortic rings in portal hypertensive rats. Eur. J. Pharmacol. 1995 273 : 167 74.
35. Himpens B, Missiaen L, Casteels R. Ca2+ homeostasis in vascular smooth muscle. J. Vasc. Res. 1995 32 : 207 19. Review.
36. Koshy A, Hadengue A, Lee SS, Jiron MI, Lebrec D. Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosis. Clin. Pharmacol. Ther. 1987 42 : 295 8.
37. Ota K, Shijo H, Kokawa H et al. Effects of nifedipine on hepatic venous pressure gradient and portal vein blood flow in patients with cirrhosis. J. Gastroenterol. Hepatol. 1995 10 : 198 204.
38. Buga GM, Griscavage JM, Rogers NE, Ignarro LJ. Negative feedback regulation of endothelial cell function by nitric oxide. Circ. Res. 1993 73 : 808 12.
39. Moller S, Gulberg V, Henriksen JH, Gerbes AL. Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic haemodynamics. J. Hepatol. 1995 23 : 135 44.
40. Okuda K, Nakashima T, Okudaira M et al. Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study. Liver 1982 2 : 176 92.
41. Lopez-Talavara JC, Merril WW, Groszmann RJ. Tumor necrosis factor α: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 1995 108 : 761 7.
42. Curran RD, Billiar TR, Stuehr DJ et al. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann. Surg. 1990 212 : 462 9 discussion 470-1.
43. Eberhardt W, Kunz D, Hummel R, Pfeilschifter J. Molecular cloning of the rat inducible nitric oxide synthase gene promoter. Biochem. Biophys. Res. Commun. 1996 25 : 752 6.